CVRx , Inc. (NASDAQ:CVRX), a medical device company with a market capitalization of $382 million specializing in the development and commercialization of the Barostim therapy for heart failure and ...
CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company specializing in mRNA-based therapies and vaccines with a market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback